| Monograph Title
|
Monograph Section
|
Scientific Liaison
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Title
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Definition
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Packaging and storage
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
USP Reference standards <11>
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Identification
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Uniformity of dosage units <905>
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Related compounds
|
|
| OFLOXACIN TABLETS PF 32(6) Pg. 1737
|
Assay
|
|
| OLEIC ACID PF 32(6) Pg. 1771
|
USP Reference standards <11>
|
|
| OLEIC ACID PF 32(6) Pg. 1771
|
Identification
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Title
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Chemical structure
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Chemical formula
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Molecular weight
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Chemical names
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Cas number
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Definition
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Packaging and storage
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
USP Reference standards
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Clarity of solution
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Identification
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Specific gravity
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Acid value
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Hydroxyl value
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Iodine value
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Saponification value
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Refractive index
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Residue on ignition
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Arsenic
|
|
| OLEYL OLEATE PF 31(6) Pg. 1670
|
Heavy metals
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
Title
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
Definition
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
Packaging and storage
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
Labeling
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
USP Reference standards
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
pH
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
Beyond-use date
|
|
| ONDANSETRON HYDROCHLORIDE ORAL SUSPENSION PF 32(1) Pg. 127
|
Assay
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
Title
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
Definition
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
Packaging and storage
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
USP Reference standards
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
Identification A, B
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
Uniformity of dosage units
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 31(4) Pg. 1104
|
Assay
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1745
|
Labeling
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1745
|
Drug release <724>
|
|
| OXYCODONE HYDROCHLORIDE EXTENDED-RELEASE TABLETS PF 32(6) Pg. 1745
|
Dissolution <711>
|
|
| OXYTOCIN INJECTION PF 32(6) Pg. 1750
|
Packaging and storage
|
|
| PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES PF 32(6) Pg. 1750
|
Uniformity of dosage units <905>
|
|
| PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES PF 32(6) Pg. 1750
|
Related compounds
|
|
| PHENOXYBENZAMINE HYDROCHLORIDE CAPSULES PF 32(6) Pg. 1750
|
Assay
|
|
| PHENYLBUTAZONE BOLUSES PF 33(1) Pg. 82
|
Definition
|
|
| PHENYLBUTAZONE TABLETS PF 33(1) Pg. 82
|
Definition
|
|
| PHENYLBUTAZONE TABLETS PF 33(1) Pg. 82
|
Labeling
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
Title
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
Definition
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
Packaging and storage
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
Labeling
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
USP Reference standards
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
pH
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
Beyond-use date
|
|
| PIROXICAM CREAM PF 32(1) Pg. 134
|
Assay
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Title
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Chemical Info
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Definition
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Packaging and storage
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
USP Reference standards <11>
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Identification
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
pH <791>
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Water, Method I <921>
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Residue on ignition <281>
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Limit of lead
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Limit of 5-hydroxymethylfurfural and related compounds
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Molecular weight limit
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Limit of monomers
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Limit of nickel
|
|
| POLYDEXTROSE PF 32(4) Pg. 1155
|
Assay
|
|
| PROGESTERONE VAGINAL SUPPOSITORIES PF 33(1) Pg. 82
|
Definition
|
|
| PROGESTERONE VAGINAL SUPPOSITORIES PF 33(1) Pg. 82
|
SUPPOSITORIES COMPOUNDED IN POLYETHYLENE GLYCOL BASE
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
Title
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
Definition
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
Packaging and storage
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
Labeling
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
USP Reference standards
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
pH
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
Beyond-use date
|
|
| QUINIDINE SULFATE ORAL SUSPENSION PF 32(1) Pg. 136
|
Assay
|
|
| RACEPINEPHRINE HYDROCHLORIDE PF 32(6) Pg. 1752
|
Identification
|
|
| RANITIDINE HYDROCHLORIDE PF 32(6) Pg. 1752
|
Chromatographic purity
|
|
| RANITIDINE HYDROCHLORIDE PF 32(6) Pg. 1752
|
Assay
|
|
| RISPERIDONE TABLETS PF 32(4) Pg. 1109
|
Related compounds
|
|
| SALICYLIC ACID PF 33(1) Pg. 83
|
USP Reference standards <11>
|
|
| SALICYLIC ACID PF 33(1) Pg. 83
|
Sulfate <221>
|
|
| SALICYLIC ACID PF 33(1) Pg. 83
|
Related compounds
|
|
| SALICYLIC ACID PF 33(1) Pg. 83
|
ID Test
|
|
| SODIUM TARTRATE PF 32(6) Pg. 1776
|
Limit of oxalate
|
|
| STEARYL ALCOHOL PF 32(6) Pg. 1777
|
Assay
|
|
| SUCCINIC ACID PF 32(6) Pg. 1777
|
Identification
|
|
| SUCCINYLCHOLINE CHLORIDE PF 32(6) Pg. 1754
|
Chromatographic purity
|
|
| SUGAR SPHERES PF 32(6) Pg. 1777
|
Particle size <786>
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
Title
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
Definition
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
Packaging and storage
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
Labeling
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
USP Reference standards
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
pH
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
Beyond-use date
|
|
| SUMATRIPTAN SUCCINATE ORAL SUSPENSION PF 32(1) Pg. 144
|
Assay
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Title
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Chemical Info
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Definition
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Packaging and storage
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Labeling
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Identification
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Acid value <401>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Iodine value <401>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Hydroxyl value <401>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Peroxide value <401>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Unsaponifiable matter <401>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Fatty acid composition
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Residue on ignition <281>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Heavy metals, Method II <231>
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Limit of erucic acid
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Content of 1-monoglycerides
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Limit of free glycerin
|
|
| SUPERGLYCERINATED FULLY HYDROGENATED RAPESEED OIL PF 32(6) Pg. 1773
|
Limit of nickel
|
|
